A robot is now being built to help stroke patients with training, motivation, and walking. In Europe, strokes are the most common cause of physical disability among the elderly. This often result in paralysis of one side of the body, and many patients suffer much reduced physical mobility and are often unable to walk on their own.
Data on ElectroCore's Vagal Nerve Stimulation Therapy GammaCore Selected for an Oral Presentation at the 65th American Academy of Neurology Annual MeetingMarch 13, 2013 9:38 am | by PR Newswire | News | Comments
MORRIS PLAINS, N.J., March 13, 2013 /PRNewswire/ -- ElectroCore®, a company dedicated to developing effective, non-invasive Vagal Nerve Stimulation (nVNS) therapies for serious medical conditions including primary headaches, announced today that data demonstrating the efficacy...
NeuroMetrix Partners with Handok Pharmaceuticals for NC-stat DPNCheck Distribution in the Republic of KoreaMarch 12, 2013 7:00 am | by The Associated Press | News | Comments
WALTHAM, Mass.--(BUSINESS WIRE)--Mar 12, 2013--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that it has entered an agreement with Handok Pharmaceuticals, Inc. Under terms of the agreement,...
NFL Commissioner Roger Goodell imagines a day in the not-too-distant future when players could be checked to determine whether their genetic makeup leaves them more likely to develop brain disease. They then might be told to switch to a less dangerous position — or give up football entirely.
GE, NFL & Leading Healthcare Experts Team up to Accelerate Concussion Research, Diagnosis & TreatmentMarch 11, 2013 1:00 pm | by The Associated Press | News | Comments
NEW YORK--(BUSINESS WIRE)--Mar 11, 2013--(NYSE: GE) – GE and the NFL today announced the Head Health Initiative, a four-year, $60 million collaboration to speed diagnosis and improve treatment for mild traumatic brain injury. The goal of the research and innovation program, guided by healthcare...
A new wireless brain implant could be an important step toward technology that lets people with mobility problems control a computer or wheelchair with their thoughts. The implant was developed by a team at Brown University in Providence, Rhode Island.
American College of Cardiology conference organizers cancel the highly anticipated presentation of preliminary results from Boston Scientific's PREVAIL study after the company leaks the data ahead of time. Boston Scientific publishes the slides that would have been presented.
The Boston Scientific Watchman@ Device Continues To Demonstrate Positive Clinical Outcomes For Patients With Atrial FibrillationMarch 9, 2013 2:24 pm | by The Associated Press | News | Comments
Boston Scientific Corporation (NYSE: BSX) reports preliminary data in the PREVAIL clinical trial met two out of three co-primary endpoints. The PREVAIL trial evaluates safety and efficacy of the WATCHMAN@ Left Atrial Appendage (LAA) Closure device in patients with nonvalvular atrial...
Boston Scientific hopes to reassure FDA regulators about the safety and efficacy of its Watchman stroke prevention implant with results from its PREVAIL study, the presentation for which was pulled from the lineup at the American College of Cardiology conference in San Francisco today.
Illumina will work with SynapDx’s to find a blood-test that could allow treatment to start earlier. Massachusetts startup SynapDx announced on Wednesday that it will work with DNA sequencer manufacturer Illumina to develop early detection tools for autism spectrum disorders, according to a release.
Federal healthcare regulators gave Ad-Tech Medical Instrument Corp.'s wide-reaching brain implant recall Class I status, the highest-risk category for medical device recalls. Late last year the Wisconsin-based medical device maker recalled its Macro Micro Subdural Electrodes over concerns that the implanted devices could cause damage to the brain.
Imaging and robotic technologies have the potential to help neurosurgeons perform precise, fast and more comprehensive testing of brain tissue during surgery, identification of cancer type, grade and tumor margins and help them navigate through the brain, according to Akash Singh , PhD. Akash Singh , PhD, performs his scientific...
Researchers explain the goals and structure of a new brain-mapping project. A proposed effort to map brain activity on a large scale, expected to be announced by the White House later this month, could help neuroscientists understand the origins of cognition, perception, and other phenomena.
Menlo Park, Calif.-based Nevro Corp. raised $48 million in a Series C financing round in support of its high-frequency spinal cord stimulation technology, including investments from Covidien Ventures and Johnson & Johnson Development Corp. Nevro develops and markets the Senza HF-SCS system for treatment of chronic pain and other disorders.
In what some are calling "a world 1st," researchers reported some success in treating severe anorexia patients via implanted electrodes that delivered electrical energy to the regions of the brain associated with emotion. The study enrolled 6 patients to receive the experimental treatment...
Class I Medical Device Recall: Ad-Tech Medical Instrument Corporation, Macro Micro Subdural ElectrodesMarch 7, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments
There is a concern the microelectrodes are defective and may cause injury to the brain. As a result, there is the potential for scraping (abrasion) of brain tissue and for broken pieces to remain in the brain tissue when the physician removes the...
Officials at Boston Scientific (NYSE:BSX) announced this week that they would reveal only limited patient safety results when they present data from a clinical trial of the Watchman stroke prevention implant at the American College of Cardiology conference this week.
We would surely all love a way to boost our brain power. But new research suggests that one promising experimental method could come with a cost. Using a noninvasive technique to stimulate the brain, researchers found they could enhance learning when they targeted a certain spot. But that also made people worse at automaticity.
Wisconsin-based medical device maker Ad-Tech Medical Instrument Corp. launched a wide-reaching recall of its Macro Micro Subdural Electrodes over concerns that the implanted devices could cause damage to the brain. The recall extends to devices manufactured from June 2006 to March 2012, according to an FDA notice.
Lower Extremity Functional Electrical Stimulation Cycling Promotes Physical & Neurological Recovery in Chronic Spinal Cord InjuryMarch 4, 2013 2:27 pm | by Bio-Medicine.Org | News | Comments
BALTIMORE , March 4, 2013 /- A new study by Kennedy Krieger Institute's International Center for Spinal Cord Injury (Epub ahead of print) finds that long-term lower extremity functional electrical stimulation (FES) cycling, as part of a rehabilitation regimen, is associated with substantial improvements in individuals with chronic spinal cord injury (SCI).
Five different psychiatric illnesses share a handful of genetic risk factors, report researchers in The Lancet. Four DNA mutations were discovered in the genomes of people who had at least one of five distinct disorders: attention deficit-hyperactivity disorder, autism, bipolar disorder, major depressive disorder and schizophrenia.
Neuro Kinetics Adds Software, Engineering Professionals as Push Continues for Improved Testing of Battlefield ConcussionsFebruary 28, 2013 9:48 am | by The Associated Press | News | Comments
Medical diagnostic device manufacturer Neuro Kinetics, Inc. said today that it has added five software and engineering professionals to its staff as the company continues to develop new testing protocols for diagnosis of concussions and other brain injuries. ...
Pairs of rats can communicate through brain chips and collaborate to perform a task, report researchers in today’s Scientific Reports. Brain activity recorded in one rat was translated into a pattern of electrical pulses that were then transmitted to another rat that had been trained to push a particular lever in response to one of two patterns of electrical stimulation in its brain.
Cognoptix begins pre-pivotal clinical trial of its drug/device test designed to identify Alzheimer’s disease via beta amyloid signature in the eyesFebruary 28, 2013 8:30 am | by The Associated Press | News | Comments
ACTON, Mass.--(BUSINESS WIRE)--Feb 28, 2013--Cognoptix announced today that it has begun a 40-patient clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer’s disease patients via a beta amyloid (“Ab”) signature in their eyes. By detecting a specific fluorescent signature of...
FDA Advisory Panel Recommends Approval of the NeuroPace RNS® System for Medically Refractory EpilepsyFebruary 26, 2013 8:00 am | by The Associated Press | News | Comments
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Feb 26, 2013--NeuroPace, Inc. today announced that on February 22, 2013 the U.S. Food and Drug Administration (FDA) Neurological Devices Panel voted unanimously (11 to 0 with two abstentions) that the clinical benefits of the NeuroPace RNS System outweigh...